Management Team

Jeremy Stackawitz: President & CEO 

Jeremy has 12+ years in healthcare including diagnostics, pharmaceutical and biotechnology. His past experiences include former Commercial Director of Immunohematology, Ortho Clinical Diagnostics, Johnson & Johnson and former Strategy Consultant to healthcare industry with Monitor and McKinsey & Co consultancies.

John Allan: Managing Director, Alba Bioscience

John has 30 years experience in diagnostics and extensive knowledge of the global blood bank market. John spent 15 years working in Hospital & Transfusion Service Laboratories in the UK and Middle East, until moving into diagnostic reagent manufacturing in 1990.

John was a Board Member at Scottish National Blood Transfusion Service from 1999 until 2007, Chairperson at EDMA Blood Typing Working Party from 1997 until 2007, a member of the EDMA representative to European Commission IVD Expert Group from 2001 until 2007, and a member of the UKBTS Reagents Standing Advisory Committee from 1994 until 2007.

Michael Hannan: VP, Marketing & Commercial Development

Mick has 20 years healthcare experience in a variety of settings. His past experience includes former Senior Director with GlaxoSmithKline in the areas of acquisitions, marketing, sales, business development and business analytics; former Senior Strategy Consultant to healthcare industry with Monitor Consulting, and former Healthcare Analyst for Dow Jones & Co.

Bill Brady: VP, Sales

Bill Brady has 28 years of transfusion products experience. He has held various senior management positions, most recently with Charter Medical, as Business Development Director for the Medical Filtration and Transfusion Therapy business, and Baxter Healthcare’s Fenwal Division of North America, as an Area Vice President with its Biotech Division.